| Name | Title | Contact Details |
|---|
Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, and listed on the Toronto Stock Exchange (TMD) and on NASDAQ in the United States (TMDI). Titan is focused on the design, development and commercialization of novel advanced robotic surgical technologies such as SPORT(TM) Surgical System. Titan`s SPORT Surgical System is a versatile single incision advanced robotic platform that features state-of the-art multi-articulated instruments with unique replaceable tips, 3D visualization on High Definition flat-screen monitor, highly ergonomic open workstation with natural surgeon interface and a single low-profile patient cart for ease of set up that enables broad applications of single and multi-quadrant surgeries. The SPORT Surgical System`s smart design elements are geared with the specific goals of delivering superior clinical capabilities and unparalleled OR efficiency at the operating costs similar to Laparoscopic Surgery in mind. Titan Medical Inc. is focused on delivering the promise of Robotic Surgery Optimized. SPORT Surgical System is currently not cleared by FDA or doesn`t have the CE mark.
SportsArt is the fitness industry leader in eco-innovation, unique design and green manufacturing excellence; and the only fitness company able to harness human energy and convert it into utility-grade electricity. We`ve built our reputation through rebuilding and sustaining lives in the fitness, medical rehabilitation, performance and wellness markets.
Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.
Biorez is dedicated to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries. We have developed the BioBrace™ scaffold, a new implant technology to reinforce tendon and ligament repairs and to facilitate tissue regeneration. Through our proprietary open porous architecture, and use of biomaterials, the BioBrace™ has been engineered to provide a high degree of bio-inductivity to promote rapid tissue regeneration, a biomechanical profile to reinforce repairs throughout the full healing profile, and full absorption overtime to fully restore the anatomy to its normal state. Early pre-clinical work suggests the BioBrace will deliver on the promise of a superior tissue scaffold to accelerate rehabilitation, regenerate functional tissue, and improve overall outcomes. Biorez is a VC-backed startup located in New Haven, CT.
Hyalex Orthopaedics is a venture backed Boston-based medical device start-up focused on developing and commercializing new products that feature HYALEX™ materials technology.